Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kathy Bochinski"'
Autor:
Paul W. Manley, Andreas Hochhaus, James D. Griffin, Barbara Wassmann, Kapil N. Bhalla, Susan O'Brien, Oliver G. Ottmann, Kathy Bochinski, Maher Albitar, Lydia Wunderle, Dieter Hoelzer, Patricia Rae, Leila Alland, Hagop M. Kantarjian, Francis J. Giles, Jorge E. Cortes, William Mietlowski, Chiaki Tanaka, Margaret Dugan
Publikováno v:
The New England journal of medicine. 354(24)
Resistance to imatinib mesylate can occur in chronic myelogenous leukemia (CML). Preclinical in vitro studies have shown that nilotinib (AMN107), a new BCR-ABL tyrosine kinase inhibitor, is more potent than imatinib against CML cells by a factor of 2
Autor:
Kathy Bochinski, Laurie Letvak, Francis Giles, M. Talpaz, D. A. Thomas, Hagop M. Kantarjian, Jorge E. Cortes, Mary Beth Rios, Susan O'Brien, Sima Jeha, Guillermo Garcia-Manero, Ralph B. Arlinghaus, Stefan Faderl
Publikováno v:
Blood. 101(1)
Fifty patients with Philadelphia chromosome–positive (Ph+) chronic myelogenous leukemia (CML) in early chronic phase received imatinib mesylate, 400 mg orally daily. After a median follow-up of 9 months, 49 patients (98%) achieved a complete hemato